Hematology: Chaired by William G. Wierda, MD, PhD

Partner | Cancer Centers | <b>MD Anderson</b>

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of hematologic cancers.

Hematology: Chaired by William G. Wierda, MD, PhD

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of hematologic cancers.

Speakers:

  • William G. Wierda, MD, PhD | The University of Texas MD Anderson Cancer Center
  • Srdan Verstovsek, MD, PhD | The University of Texas MD Anderson Cancer Center
  • Jason Westin, MD, FACP | The University of Texas MD Anderson Cancer Center
  • Sattva S. Neelapu, MD | The University of Texas MD Anderson Cancer Center

Topics:

  • Chronic Lymphocytic Leukemia
  • Future Directions in Myelofibrosis
  • Diffuse Large B Cell Lymphoma
  • CAR T